Medical Innovation Exchange

Celyad's CAR-T cleared by FDA in phase 1 Keytruda combo trial, but nature of 2 deaths still unclear


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.